Brenda Arnett, MD - Internal Medicine

Dr. Brenda Arnett
Internal Medicine, PLC

Publications

Arnett B, Soisson P, Ducatman BS and Zhang P. Expression of CAAT enhancer protein beta (C/EBP beta) in cervix and endometrium. Molecular Cancer 2(1): 21, April 2003.

Herzig MC, Rodriguez KA, Trevino AV, Dziegielewski J, Arnett B, Hurley L and Woynarowski JM. The genome factor in region-specific DNA damage: a DNA-reactive drug U-78779 prefers mixed A/T G/C sequences at the nucleotide level but is region-specific for long pure AT islands at the genomic level. Biochemistry 41(5): 1545-55, 2002.

Woynarowski JM, Faivre S, Herzig MC, Arnett B, Chapman WG, Trevino AV, Raymond E, Chaney SG, Vaisman A, Varchenki M and Juniewicz PE. Oxaliplatin-induced damage of cellular DNA. Molecular Pharmacology 58(5): 920-7, 2000.

Woynarowski JM, Napier C, Trevino AV and Arnett B. Region-specific DNA damage by AT specific DNA reactive drugs is predicted by drug binding specificity. Biochemistry 39(32): 9917-27, 2000.

Herzig MC, Trevino AV, Arnett B and Woynarowski JM. Tallimustine lesions in cellular DNA are AT sequence-specific but not region-specific. Biochemistry 38(42): 14045-55, 1999.

Herzig MC, Arnett B, MacDonald JR and Woynarowski JM. Drug uptake and cellular targets of hydrozymethylacylfulvene (HMAF). Biochemical Pharmacology 58(2): 217-25, 1999.

Abstracts and Presentations

"Multiple Sclerosis." Women's Health Forum, Rapid Rehabilitation, Front Royal, VA, May 17, 2007.

"Update in Women's Health." Medical Ground Rounds, Virginia Hospital Center, Arlington VA, Sept. 23, 2003.

Expression of CAAT Enhancer Binding Protein beta (c/EBP) in Endometrium. Presented at the WVU Dept. of OB/GYN's Resident Research Presentation Day, May 2002.

Woynarowski JM, Koester S, Woynarowska B, Arnett B, Trevino AV, Chan D, Higdon A, Munoz R, Herzig MC and Faivre S. Is drug-induced DNA damage sufficient for apoptosis induction? 1999 Annual AACR Meeting, abstract 4862.

Woynarowski JM, Trevino AV, Arnett B, Faivre S, Chaney S, Vaisman A and Varchenko M. DNA interstrand cross-links and DNA-protein cross-links by oxaliplatin. 1999 Annual AACR Meeting, abstract 1951.

Herzig MC, Trevino AV, Arnett B and Woynarowski JM. Site- and region-specificity of tallimustine lesions in cellular DNA. 10 th NCI-EORTC Symposium on New Drugs in Cancer Therapy, Amsterdam, June 1998, Proceedings Abstract 527.

Woynarowski JM, Hardies SC, Trevino AV and Arnett B. Targeting of AT-rich island in genomic DNA by bizelesin, an AT-specific DNA-reactive antitumor drug. 10 th NCI-EORTC, Amsterdam, June 1998, Proceedings Abstract 528.

Herzig MC, Arnett B, MacDonald J and Woynarowski JM. Uptake and macromolecular binding of 6 hydroxymethylacylfulvene (HMAF, MCI 114) in a leukemic cell line, CEM. Proc. American Assoc Cancer Res. 39, 66, 1998.

Questions? Comments? Please contact us.